Clinical outcomes of patients with metachronous second primary lung adenocarcinomas

BACKGROUND: The incidence of adenocarcinomas as multiple primary lung cancers (MPLCs) is increasing. How to determine the treatment strategies of MPLCs, especially second primary lung adenocarcinomas (SPLACs), and the prognostic factors associated with it are unclear. METHODS: The clinical records o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Heng, Yang, Haitang, Han, Ke, Xu, Jianlin, Yao, Feng, Zhao, Yang, Fan, Liwen, Gu, Haiyong, Shen, Zhenya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237587/
https://www.ncbi.nlm.nih.gov/pubmed/28138252
http://dx.doi.org/10.2147/OTT.S122908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237587/
https://www.ncbi.nlm.nih.gov/pubmed/28138252
http://dx.doi.org/10.2147/OTT.S122908

Ejemplares similares